Saint Luke's Newsroom

Apr. 28, 2022

KSHB: Organ Donation Creates Lifelong Bond Between Two Missouri Women

KSHB talked to one woman who donated part of her liver and was inspired to become a transplant coordinator at Saint Luke's to help others.

Apr. 28, 2022

Lawrence Times: Promise of Transplant Begins to Awaken Family from 'Nightmare' Year of Illness and Loss

After a COVID-19 infection caused end-stage renal disease, Angela Dotson says the recent promise of a kidney transplant means hope is on the horizon.

Apr. 26, 2022

KMBC: Missouri Woman and Three-Time Recipient Says Organ Donation Gave Life Back to Her

KMBC talked to Dr. Matthew Wilkinson about the important role of living donors and why everyone should consider signing up to become a potential donor.

Apr. 26, 2022

KSHB: Wastewater Trends Show COVID Up 40% in Parts of the Metro

KSHB talked to Dr. Sarah Boyd about what the wastewater trends typically mean for future hospitalizations.

Apr. 20, 2022

Congress Report: Results from the EMPULSE Trial

Dr. Mikhail Kosiborod talks about the additional analysis from the EMPULSE trial presented at the American College of Cardiology congress.

Apr. 19, 2022

KSHB: Local Health Experts, Travelers React to Federal Judge's Ruling on Mask Mandate on Public Transportation

KSHB talked to Dr. Ginny Boos about the risk of traveling without a mask and why wearing a face covering may still be a good idea.

Apr. 18, 2022

FOX4: Saint Luke's Patient Pays It Forward to His Care Team

After David's recent stay at the hospital, he reached out to the FOX4 Pay It Forward team to nominate his team of doctors and nurses for taking good care of him.

Apr. 16, 2022

Lee's Summit Tribune: U.S. News & World Report Names Saint Luke’s East Hospital A High Performing Hospital For The Best Hospitals For Maternity

This is the first time U.S. News has published a list of Best Hospitals for Maternity.

Apr. 15, 2022

Medscape: Empagliflozin Rapidly Improves Acute Heart Failure Symptoms in Hospitalized Patients

EMPULSE trial shows treatment of patients acutely hospitalized for heart failure with empagliflozin led to a rapid incremental increase in patient well-being, compared with control patients who received placebo.